GenEng News  Mar 30  Comment 
The ability to recapitulate closely the cellular environment in which a new drug compound will be exposed once inside the body is the goal most scientists strive toward during the drug development process. However, creating 3D cellular systems has...
Commodity Online  Nov 22  Comment 
The team at Stanford developed gecko inspired synthetic adhesives that can share large loads evenly. The team and rsquo;s work has created the adhesive, which is sufficient enough to allow a person to climb a glass wall.
TechCrunch  Aug 7  Comment 
 Imagine a biomimetic robot that can inflate itself, bend at odd angles, and channel liquids through itself in any direction. That’s what scientists at Harvard University have created. By using squishy little Lego blocks with channels built-in,...
SeekingAlpha  Mar 12  Comment 
By Stephen Simpson, CFA: Wright Medical's (WMGI) acquisition of BioMimetic Therapeutics and its Augment biological product for bone healing has been almost nothing but trouble. At seemingly every turn the FDA has thrown up obstacles to Augment,...
TechCrunch  Aug 15  Comment 
Today in our continuing series entitled "Robots That Will Eventually Drink The Liquid From Your Eyeball In Your Sleep" we present the STAR.V3, a superfast, 3D-printed robot that can squeeze itself down to fit underneath a door and/or scuttle...
StreetInsider.com  Mar 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Wright+Medical+Group+%28WMGI%29+Completes+%24380M+Acquisition+of+BioMimetic/8145656.html for the full story.
StreetInsider.com  Feb 5  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BioMimetic+%28BMTI%29+Receives+Informal+Request+from+FDA+for+Augment+PMA/8059289.html for the full story.
StreetInsider.com  Jan 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BioMimetic+%28BMTI%29+Says+Class+Action+Suit+Dismissed+in+Tennessee/8004880.html for the full story.
StreetInsider.com  Jan 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BioMimetic+%28BMTI%29+Initiates+Phase+II+for+ACT+as+Lateral+Epicondylitis+Treatment/7980282.html for the full story.
Benzinga  Nov 21  Comment 
In a report published Wednesday, Loewen Ondaatje McCutcheon downgraded its rating on BioMimetic Therapeutics (NASDAQ: BMTI) from Buy to Hold, but reiterated its $7.50 price target. Loewen Ondaatje McCutcheon noted, “With BMTI trading within...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki